Solid-organ transplants increase the risk of death due to cancer compared with the general population, a study published in JAMA Oncology has found. Solid-organ transplants increase the risk of death ...

In a study published today in the journal Clinical Infectious Diseases, a Johns Hopkins Medicine research team reports that for XBB.1.5, there is good news for solid organ transplant recipients (SOTRs ...

In a recent study posted to the medRxiv* preprint server, researchers estimated the humoral immunity imparted by the two/three doses of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. During the study period, 11.4% of solid organ transplant ...

Researchers evaluated 37 SOTRs (mean age, 70.7 years; 35 men) between May and December 2024. Each participant was at least 1 year post-transplant and had four to eight AKs on two 25-cm² areas of the ...

In a meta-analysis of solid organ transplant recipients with advanced cancer taking immune checkpoint inhibitors, half of patients died and 1 in 5 experienced graft loss. In solid organ transplant ...

Following a second bivalent booster, many SOTRs regained the ability to neutralize both virus strains; yet 42% did not have any detectable immunity to XBB.1.5. The researchers found that those SOTRs ...

Please provide your email address to receive an email when new articles are posted on . A tool designed to assess skin cancer risk in solid organ transplant recipients proved to be efficacious in ...

Research finds that booster doses of bivalent vaccines given every three to six months helps maintain a person's ability to neutralize multiple SARS-CoV-2 strains, including XBB.1.5 People who have ...